Vor Biopharma VOR Q2 2025 earnings
Reported August 12, 2025 · Before market open
EPS estimate-$11.40
Next report
Aug 11, 2026 (In 4 weeks)EPS estimate-$0.69
Financials
Q2 2025Versus estimates
Diluted EPS
Ask the moment Vor Biopharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Vor Biopharma report Q2 2025 earnings?
- Vor Biopharma (VOR) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Vor Biopharma's Q2 2025 revenue and EPS?
- Vor Biopharma reported diluted EPS of $-43.60 for Q2 2025.
- Did Vor Biopharma beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-11.40 by $32.20.
- How did Vor Biopharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 10534.1% from $-0.41.
- Where can I find Vor Biopharma's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-107276) directly on SEC EDGAR. The filing index links above go to sec.gov.